ACTIVE

Magis-Pharma

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
-374,5 k €
+74.3% YoY
Revenue
14,7 M €
+4.3% YoY
Equity
248 k €
-60.2% YoY
Workforce
55,2 ETP
+9.1% YoY

What does Magis-Pharma do?

Magis-Pharma is a Public limited company incorporated in 2015. Its registered office is in Antwerpen. It employs on average 55,2 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0644.784.239
Incorporation
22/12/2015
Legal form
Public limited company
Registered office
Neerlandweg 24
2610 Antwerpen · FlandreSee on map
Contributed capital
863 206,20 €
Latest accounts
31/12/2025
Average workforce
55,2 ETP
Joint committees (1)
  • 207
Signals
Positive cashflowPositive EBITDAHealthy social debtsHigh revenue
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 10 financial years

2025202420232022202120202019201820172016
Income statement
Revenue14,7 M €14,1 M €12,2 M €12 M €15,3 M €–––––
EBITDA783,1 k €-497,2 k €100,6 k €351,9 k €1,8 M €1,1 M €496,9 k €-424,3 k €-190,3 k €-336,8 k €
Operating result95,9 k €-1,2 M €-106,9 k €205,9 k €1,6 M €959,4 k €424,6 k €-481,7 k €-232,8 k €-342,6 k €
Net result-374,5 k €-1,5 M €-275,4 k €36 k €1,1 M €834,2 k €384,1 k €-488,6 k €-255 k €-350,1 k €
Balance sheet
Equity248 k €622,5 k €1,8 M €2,1 M €2 M €920,4 k €86,2 k €-297,9 k €90,7 k €-100,1 k €
Total assets12,5 M €11,6 M €7,5 M €5,3 M €5,9 M €3,1 M €2 M €1,4 M €830,6 k €359,7 k €
Cash93,4 k €776,7 k €470,4 k €100,8 k €1,4 M €384,8 k €3,4 k €8,3 k €75,5 k €22,4 k €
Debts12,3 M €10,9 M €5,7 M €3,3 M €3,8 M €2,1 M €1,8 M €1,5 M €719,4 k €454,5 k €
Other
Workforce55,2 ETP50,6 ETP16,6 ETP14,0 ETP12,5 ETP9,8 ETP8,3 ETP6,5 ETP–1,5 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 24 ended

Active mandates

GREEN MONKEY

Managing director · since 31 mars 2026 · until 24 février 2032 · 0799.106.091

Represented by Christophe Bouvry

Active
Jeroen van der Hamsvoort

Director · since 31 mars 2026 · until 24 février 2032

Active
Paulus de Vogel

Director · since 31 mars 2026 · until 24 février 2032

Active

Ended mandates

DB Consortium

Managing director · since 31 janvier 2024 · until 27 février 2029 · 0645.962.788

Represented by Bergers DAAN

Ended
BALANSA

Director · since 19 avril 2021 · until 19 avril 2027 · 0471.789.390

Represented by Ludwig Geldof

Ended
BALANSA

Director · since 19 avril 2021 · until 19 avril 2027 · 0471.789.390

Represented by Geldof LUDWIG

Ended
BD Strategy Comm. V.

Managing director · since 19 avril 2021 · until 19 avril 2027 · 0764.987.827

Represented by Daan Bergers

Ended
At this address

Other companies at this address

CompanyCBE no.
MAGIS GROUP● Active
0756.779.449
Magis Pharma Group● Active
0765.834.004
Annual accounts

Full financial information

202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date16/07/202623/10/202529/04/202403/08/202329/06/202209/08/2021
General meeting30/06/202621/10/202525/04/202407/07/202306/05/202207/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

10 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202530/06/202616/07/2026DutchPDF
Full model31/12/202421/10/202523/10/2025DutchPDF
Full model31/12/202325/04/202429/04/2024DutchPDF
Full model31/12/202207/07/202303/08/2023DutchPDF
Full model31/12/202106/05/202229/06/2022DutchPDF
Abridged model31/12/202007/05/202109/08/2021DutchPDF
Abridged model31/12/201910/06/202009/07/2020DutchPDF
Abridged model31/12/201803/05/201905/08/2019DutchPDF
Micro model31/12/201704/05/201801/06/2018DutchPDF
Abridged model31/12/201605/05/201706/06/2017DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 24 ended

Active mandates

GREEN MONKEY

Managing director · since 31 mars 2026 · until 24 février 2032 · 0799.106.091

Represented by Christophe Bouvry

Active
Jeroen van der Hamsvoort

Director · since 31 mars 2026 · until 24 février 2032

Active
Paulus de Vogel

Director · since 31 mars 2026 · until 24 février 2032

Active

Ended mandates

DB Consortium

Managing director · since 31 janvier 2024 · until 27 février 2029 · 0645.962.788

Represented by Bergers DAAN

Ended
BALANSA

Director · since 19 avril 2021 · until 19 avril 2027 · 0471.789.390

Represented by Ludwig Geldof

Ended
BALANSA

Director · since 19 avril 2021 · until 19 avril 2027 · 0471.789.390

Represented by Geldof LUDWIG

Ended
BD Strategy Comm. V.

Managing director · since 19 avril 2021 · until 19 avril 2027 · 0764.987.827

Represented by Daan Bergers

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Restructuring08/09/2026
    MET FUSIE DOOR OVERNEMING GELIJKGESTELDE VERRICHTING
    PDF
  • Restructuring23/06/2026
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Mandates05/06/2026
    ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates26/11/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates26/08/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Restructuring26/06/2024
    DOEL - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...) - DIVERSEN
    PDF
  • Restructuring06/11/2023
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Registered office18/10/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - BENAMING - MAATSCHAPPELIJKE ZETEL
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-374,5 k €↑
  2. 2024
    Annual accounts 2024-1,5 M €↓
  3. 2023
    Annual accounts 2023-275,4 k €↓
  4. 2023
    Name changeMagis-Pharma
  5. 2022
    Annual accounts 202236 k €↓
  6. 2021
    Annual accounts 20211,1 M €↑
  7. 2021
    Name changeFac Secundum Artem
  8. 2020
    Annual accounts 2020834,2 k €↑
  9. 2019
    Annual accounts 2019384,1 k €↑
  10. 2018
    Annual accounts 2018-488,6 k €↓
  11. 2017
    Annual accounts 2017-255 k €↑
  12. 2016
    Annual accounts 2016-350,1 k €
  13. 22/12/2015
    IncorporationPublic limited company